instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
Wiping her face with a cotton pad after a Botox injection, the 49-year-old supermarket worker said she has cut down on petrol and entertainment to afford the treatments, which make the skin appear smoother by temporarily paralyzing muscles. "I want to look at myself in the mirror and feel good. I'm afraid of aging," Vorlioti said. "Work, the crisis, they push you down and you want something uplifting." She is not the only one seeking solace in beauty treatments amid a financial crisis that cut hundreds of thousands of jobs cut, slashed salaries and caused a sharp decline in life satisfaction among Greeks. In fact, it seems Greece is undergoing what has been dubbed the "lipstick effect", where consumers turn to low cost beauty to boost their mood during economic depressions. Non-surgical procedures in Greece soared to more than 220,000 in 2016 compared to around 61,000 in 2010, the biggest jump in Europe in the six-year period, according to data by the International Society of Aesthetic Plastic Surgery (ISAPS). At between 80 and 150 euros a pop, it doesn't come cheap for Greeks, who earn an average net monthly income of about 780 euros. Some, like Vorlioti, need to save up for months in order to be able to afford a treatment and yet more are choosing to have them, doctors say. "The crisis has brought new people to the doctor's doorstep, people who wouldn't come before, both men and women who are struggling and want to improve their looks to feel better," said Lia Papadavid, a dermatologist. "It's like giving themselves a present," she told Reuters shortly after giving a middle-aged female a filler injection around her eyes. The rise in Greece follows a world-wide upward trend in non-surgical procedures. It ranked 14th in the world among the top 24 countries in terms of volume of non surgical treatments in 2016, behind countries such as Italy and Germany but above Belgium, according to ISAPS. Surgical treatments, which can cost thousands of euros, are up only 10 percent since 2010. Waiting her turn at the Athens Aurum medical center, 43-year-old Eleni says she turned to injectables in 2013 and has not stopped despite the crisis. "No one has money to spare, everyone is being pressured right now with the crisis, some less, some more. I think it needs a bit of planning, and to love yourself." Investment in the beauty industry doubled between 2009-2015, said the Hellenic Federation of Enterprises in a July report. New nail bars and beauty centers have popped up in central Athens and in the central Syntagma square, young men and women are seen handing out flyers advertising discounts on cosmetic services to passers-by. Chairman of the ISAPS Education Council Paraskevas Kontoes said the surge in non invasive treatments could be explained by their low cost, better results thanks to new technology and people needing to boost their self-esteem battered by years of crisis. Non surgical beauty treatments are fast enough to have in a lunch break, but their effects are only temporary. Results can last eight months or longer depending on the product, Dr Stefanos Stathakis said. He also said most people choose treatments for the face, tying in with other doctors' reports that their clients believe they can help them score better in a job interview, particularly as competition for jobs in Greece is fierce. "They believe it will become easier for them to get a job," said Vorlioti's dermatologist Froso Saksioni. "People struggle and come here for a change. If you charge them a fortune for a treatment it's like giving them a slap instead." As Saksioni prepares for "a vampire lift", where the doctor withdraws and then reinjects a patient's blood to erase wrinkles, Vorlioti books her next appointment. "I've decided to cut down on everything else to do this", she said. "When I feel good about myself, I think it shows."
answer:
The lipstick effect: Greeks discover need to pamper in crisis.

question:
The release does not mention cost or whether it's covered by private insurance or Medicare, and in this case, it's a pretty big omission. This may be an enormously expensive treatment for patients and it's why we have a cost criterion in our reviews. The hopeful psoriasis patient who sees this release without a cost discussion might already have their hand on the phone to call their dermatologist. Here's a very rough estimate of what that patient might face in terms of cost: Based on a conservative wholesale price of roughly $4,000 per 80mg injection and following the recommendation (found on the package insert) of twoinjections every two weeks for 12 weeks, followed by monthly injections, we calculated $48,000 for the first 12 weeks plus $36,000 for the following 9 months or $84,000 total. The release stated that by week 12,"76.4 to 81.8 percent of patients had their psoriasis classified as "clear" or "minimal" compared to 3.2% of patients on the placebo. By the 60th week, 68.7 to 78.3 percent of patients had maintained their improvement." We also wanted more detail on the measured strength of the response for each patient. For example, what constitutes "minimal"? The release adequately addresses harms and notes that long-term side effects are unknown with this sentence: "Adverse events associated with ixekizumab included slightly higher rates of neutropenia (low white blood cell count), yeast infection and inflammatory bowel disease compared to the placebo. The safety of therapy longer than 60 weeks will need to be monitored in the future." The release clearly and thoroughly describes the three phase 3 international trials at 21 sites, that they enrolled a large number of patients, and that they were randomized and controlled. There was no disease mongering. The release describes what psoriasis is and its prevalence, and explains that these trials were for moderate to severe psoriasis which covers at least 10 percent of the body. The release is very transparent in stating that the drug manufacturer paid for the research and that the lead researcher is a paid consultant to Eli Lilly. The release did not compare the many different ways that patients treat psoriasis, some with topical agents and some with oral steroids or other medications. The release states that the drug has been approved by the FDA following the completion of the trials. This is a strong indication that the drug is or soon will be available. The release should have noted that the drug is already being marketed under the brand name Taltz. The release makes an understated claim to novelty with this quote from the lead researcher: "Ten years ago, we thought complete clearance of this disease was impossible. It wasn't something we would even try to do. Now with this drug, we're obtaining response levels higher than ever seen before." There was no unjustifiable language in the release.
answer:
New drug clears psoriasis in clinical trials

question:
"Congress may have no greater trade-agreement foe than Sherrod Brown, the Democratic U.S. senator from Ohio. It's not that he says selling cars, soap and widgets to foreign consumers is bad. It's just that some foreign trading partners use their cheap labor and weak environmental and safety standards to sell cars, toys and widgets to Americans at prices that our domestic industries cannot match while, according to Brown, adopting policies that make it hard to sell America's goods abroad. So Brown was not saddened when negotiations for a South Korean trade deal went sour in November. After all, he said in a news release, more than 10 years of free trade deals have ""brought a $2 billion per day trade deficit and the loss of millions of manufacturing jobs -- jobs that should go to Ohio's skilled workers."" PolitiFact and The Plain Dealer expended plenty of bytes and ink on the lost-jobs issue during the election season, so there is no need to wade back into it here. Let's just say that a persuasive case can be made, although the underlying data on jobs is poor. This country can send a man to the moon but it cannot precisely quantify the number of jobs lost or gained to trade. But what about Brown's other point -- that more than 10 years of trade under the North American Free Trade Agreement and trade relations with China has resulted in a trade deficit of $2 billion a day? Causation of that kind is in dispute, and some experts and data suggest this country's reliance on oil plays a big role in the trade deficit, with OPEC countries selling $76.4 billion more to the United States than vice versa so far this year. But imbalances with China ($201 billion and counting so far this year) play a bigger role, government statistics show. We will not argue cause and effect here, nor will we tell you not to enjoy low-price consumer goods. We're merely examining the numbers. They show that the negative balance of trade went from $70.3 billion in 1993, just before NAFTA, to $378.8 billion in 2000, as the United States accepted permanent normalized trade with China, to a record high of $759.2 billion in 2006, according to Commerce Department records. So what of Brown's precise number, $2 billion a day? Brown is right -- kind of. Or he's not right, sort of. This drives us nuts too, but as we dug into the subject, we realized that different groups use different measures to describe the size of the trade deficit. You'd think it would be as easy as comparing the value of goods and services exported from the United States with those imported from other countries. So let's show you some numbers from the Commerce Department using that exact measure. Trade deficit for 2007: $702 billion. For 2008: $698.8 billion. For 2009: $374.9 billion. The recession's effects were glaring, but even before then the trend was downward, albeit slightly. For January through September 2010, the most recent measurement available, the trade balance was a negative $379.1 billion. Assuming the monthly trends hold through December, this year's annual trade deficit should reach $500 billion. Divide that by the days of the year and you'd have a daily trade deficit of $1.37 billion a day. That's 32 percent lower than Brown's claim of $2 billion a day. But since flush times will return eventually, imports and exports will presumably resume at robust levels, too. So if Brown was referring to the trade deficits that existed before the recession, his statement would be nearly accurate, because the deficit came to an average of $1.91 billion a day in 2008 and $1.92 billion a day in 2007. But it may not be that simple. Trade balances are affected not only by wages, tariffs and the demands of consumers, but also by events beyond the recession such as currency corrections and the value of the dollar. Considering recent currency corrections, annual trade deficits could stay in the range of $500 billion, said William Cline, a senior fellow at the Peter G. Peterson Institute for International Economics. That would make Brown's $2 billion-a-day figure somewhat high. ""It's a bit of an outdated figure,"" Cline said.. Yet there's another way of viewing the data. Figures from the Commerce Department that we reviewed originated from the U.S. Census Bureau's economic analysis unit (a bureau within a bureau at Commerce). The figures are the government's official measure of the trade balance, used by the White House, cited in the news media and accepted broadly by economists. Yet the U.S. International Trade Commission, or ITC, which polices trade matters in the United States, maintains separate data that is used to review tariffs and trade practices. Depending on how one chooses to sort the data, a higher trade deficit can result. Brown's office told us that his data came from the ITC. So we, too, turned to the ITC, and its staff helped guide us in using its online database. The ITC cautioned that the official figures come from Commerce, but various trade professionals use ITC data to drill down further for other purposes. We drilled. The result: A much higher trade deficit -- as high as $500.9 billion last year, in the depths of the recession, and $800 billion -- averaging $2.19 billion a day -- for 2008. How can one agency have such different figures from another? It's easy. The ITC, concerned with tariffs, trade laws and trade policy, measures the value of goods -- cars, factory equipment, steel -- but not services. Services represent only a portion of the trade universe, yet they add a sweet spot to the equation. This country had a $132 billion trade surplus in services last year because it exported more in the way of travel, financial services, information services and so forth, than it brought in. Take away those services -- or just look at the ITC numbers -- and the trade balance becomes more bleak. It's important to remember that when the White House and news reports mention the trade deficit, they are including services as well as goods and relying on the Commerce numbers. Even the ITC stressed this with us. But Brown aides as well as representatives of Public Citizen, a liberal public interest group, and its Global Trade Watch project, say the ITC data can be more relevant in certain circumstances. A state like Ohio exports relatively little in the way of services, for example, so the ITC's focus on goods may be more pertinent for measuring trade's impact in Ohio, said Todd Tucker, research director for Global Trade Watch, and Chris Slevin, a Brown aide who previously worked as Global Trade Watch's deputy director. Even nationally, there is debate as to how much job-creating value can be found in export sectors like financial services and travel, Tucker said. Factories that make things employ a lot more people. Not to complicate this further, but ITC data can be sorted in yet another way, making the trade imbalance appear to be even worse. This occurs when some foreign-made goods are counted as ""imports for consumption,"" an ITC category with an assumption at the port of entry that the goods will be consumed in the United States. The problem occurs, critics say, when these ""imports"" wind up being shipped back abroad after being stored here temporarily. That gives them a new category on the way out -- ""re-exports"" -- which is not the same as a simple export of a product made in the United States. So they were counted as imports on the way in, but not subtracted back out as regular exports on their way out. This kind of counting, which defenders say has merit in certain circumstances, results in a higher trade deficit than when every product shipped in is counted as an import, and every product shipped out is counted as an export. By using these other categories in the ITC database, we calculated a trade deficit of $612 billion last year and a stunning $920.6 billion in 2008. These are close to the numbers Brown's office supplied to us initially, and they support his claim -- and then some. So which figure is right? It's a matter of legitimate dispute. Global Trade Watch says the larger numbers are more revealing and pertinent in a number of cases, especially when comparing U.S. trade relations with individual countries rather than the entire universe of global trade. The National Association of Manufacturers says that's nonsense. From ""time immemorial,"" the Commerce/Census data have been used, measuring the total value of goods and services in and the total value of goods and services out, and that's the only valid way to count a deficit or surplus, said Frank Vargo, the association's vice president for international economic affairs. ""Inside U.S. Trade,"" a publication for trade policy wonks and attorneys, discussed this at length in a Nov. 12 article. It said that ""these different approaches result in widely different numbers when applied to both the global and bilateral deficits, and they have helped fuel and confuse a debate among stakeholders."" Global Trade Watch is sticking to its guns, but so is the National Association of Manufacturers. So back to Brown's $2-billion-a-day claim: Is it accurate? Brown, who has authored a book on what he calls the ""myths of free trade,"" derives his figure from the ITC, and while the ITC cautioned us that the official balance-of-trade measure actually comes from Commerce, it is true that some authorities regard even the outlying ITC numbers as perfectly fine to use in certain circumstances. Yet even if we were to put those numbers aside and only use the Commerce Department numbers, Brown's figures were close to the mark before the recession. This year is not the best year to measure the normal effects of trade, and no one can predict the future; perhaps the trade deficit will stabilize at a lower number such as $500 billion a year, or $1.36 billion a day. Perhaps it won't. But based on the historical trends, regardless of which data source is used, we say Brown's claim is ."
answer:
More than 10 years of free trade "has brought a $2 billion per day trade deficit.